Pan Cancer T

About Pan Cancer T

Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors.

Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.

Address

• Headquarters

  Marconistraat 163029 RotterdamZuid-Holland, Netherlands

Team by function

Based on 12 public job profiles as of 4 September 2026.

• Research / R&D3
• Executive / C-Suite2
• Healthcare / Medical2
• Other / Unclassifiable2
• Engineering / Software Development1
• Finance / Accounting1
• Founder / Owner1